Bio Green Med Solution (BGMS) Interest Expenses (2010)
Bio Green Med Solution (BGMS) posted quarterly Interest Expenses of $13911.0 for Q1 2026, up 247.77% year-over-year from $4000.0 in Q1 2025, and up 1291.1% quarter-over-quarter from $1000.0 in Q4 2025.
Analysis
Bio Green Med Solution (BGMS) Interest Expenses (2010) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Interest Expenses for 17 consecutive years, with $13911.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 247.77% year-over-year to $13911.0; the TTM figure through Mar 2026 stood at $20853.0 (down 71.33% YoY), while the FY2025 annual figure was $4.1 million, up 3505.26% from the prior year.
- Interest Expenses grew to $13911.0 in Q1 2026 per BGMS's latest filing, from $1000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $197000.0 in Q2 2022 and bottomed at $1000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $52307.4 across 5 years, with a median of $28000.0 in 2025.
- Annual changes were most pronounced in 2022 — Interest Expenses sank 99.01% — and 2026, when it jumped 247.77%.
- Bio Green Med Solution's Interest Expenses stood at $48511.0 in 2022, then dropped by 1.56% to $47755.0 in 2023, then slumped by 95.93% to $1942.0 in 2024, then plunged by 48.51% to $1000.0 in 2025, then soared by 1291.1% to $13911.0 in 2026.
- Business Quant data shows BGMS's Interest Expenses at $13911.0 in Q1 2026, $1000.0 in Q4 2025, and $28000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 3,000.00 |
| Sep 30, 2010 | 7,000.00 |
| Jun 30, 2010 | 9,000.00 |